Empagliflozin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Empagliflozin and local guidelines before prescribing.
Mechanism
SGLT2 inhibitor increasing urinary glucose and sodium excretion.
Uses
Type 2 diabetes, heart failure, chronic kidney disease.
Dosing
- Dapagliflozin / empagliflozin | 10 mg once daily for eligible heart failure, with or without diabetes; sick-day rules.
Cardiology: Valvular heart disease › 4.40 Drug Reference Table - Drugs Dapagliflozin 10 mg daily. Empagliflozin 10 mg daily.
Cardiology: Heart Failure › 2.21 💊 SGLT2 Inhibitors - Empagliflozin | 10 mg once daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Dapagliflozin / empagliflozin | Heart failure: 10 mg once daily; sick-day rules; check eGFR thresholds.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
4 more dose entries from the chapters
- Examples: Dapagliflozin 10 mg, empagliflozin 10 mg (25 mg for extra glucose lowering), canagliflozin 100–300 mg, ertugliflozin - once daily.
Endocrinology: Diabetes - Dapagliflozin / empagliflozin Type 2 first-line with metformin; HF; CKD | 10 mg once daily (empagliflozin 25 mg for extra glucose lowering). Genital infection, volume depletion, euglycaemic DKA. Sick day rules; omit around surgery.
Endocrinology: Diabetes - Empagliflozin 10 mg daily (TA942) - eGFR 20–45 , or eGFR 45–90 with ACR 22.6 or more or type 2 diabetes.
Renal: Chronic Kidney Disease - Empagliflozin 10 mg daily | CKD (TA942): eGFR 20–45, or 45–90 with ACR 22.6 or more or type 2 diabetes.
Renal: Chronic Kidney Disease
Side effects
Genital infections, urinary infection, volume depletion, euglycaemic ketoacidosis, Fournier gangrene.
Interactions
Diuretics increase volume depletion; insulin and sulfonylureas increase hypoglycaemia risk.
Contraindications and cautions
Ketoacidosis history
Monitoring
eGFR, ketones if unwell
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Less glucose lowering at low eGFR; heart and kidney benefit continue
Overdose and reversal
Supportive
Special advice
Sick-day rules and pre-operative stopping; ketone check if unwell.
More from the textbook: uses, cautions and other points
- Drugs - dapagliflozin , empagliflozin .
Cardiology: Anatomy Physiology and Pharmacology - Dapagliflozin / empagliflozin | SGLT2 inhibitors; heart failure, CKD; genital infections, euglycaemic DKA; sick day rules.
Cardiology: Anatomy Physiology and Pharmacology - Recommended treatment approach : SGLT2 inhibitor: Consider dapagliflozin or empagliflozin, including in suitable patients without diabetes; MRA: NICE 2025 recommends considering an MRA, with careful monitoring of renal function and potassium; Loop diuretics: Use when fluid retention or congestion is present; Hypertension: Treat …
Cardiology: Heart Failure › 2.24 💊 Management of HFpEF - NICE TA388: Sacubitril/Valsartan - ARNI treatment in HFrEF; NICE TA902: Dapagliflozin - heart failure with mildly reduced or preserved ejection fraction; NICE TA929: Empagliflozin - chronic heart failure with preserved or mildly reduced ejection fraction.
Cardiology: Heart Failure › 2.42 📌 NICE and European Guidelines - Examples - dapagliflozin, empagliflozin, canagliflozin, ertugliflozin.
Endocrine: Anatomy Physiology and Pharmacology - Dapagliflozin / empagliflozin | SGLT2; heart and kidney benefit; thrush, euglycaemic DKA, Fournier's; stop on sick days and before surgery.
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Heart Failure (4 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (4 mentions)
- Endocrinology: Diabetes (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (3 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (2 mentions)
- Integrated cardiology chapter (6 mentions)